Lido Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Lido Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $100,964 - $117,774	-1,048 Reduced 17.39%	4,979 $512,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $18,137 - $19,181	-169 Reduced 2.73%	6,027 $657,000
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $24,332 - $44,382	-390 Reduced 5.92%	6,196 $705,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $3,770 - $5,418	-64 Reduced 0.96%	6,586 $407,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $126,643 - $185,594	-1,595 Reduced 19.35%	6,650 $530,000
Q1 2022 May 17, 2022	SELL	$86.42 - $109.81 $170,074 - $216,106	-1,968 Reduced 19.27%	8,245 $867,000
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $405,377 - $493,189	4,113 Added 67.43%	10,213 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $560,651 - $673,257	6,100 New	6,100 $668,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.